HealthPlus Network of Specialty Centers in Abu Dhabi

Book An

Appointment
Call us

600 503035
Book An

Appointment
Call us

600 503035

M42’s Imperial College London Diabetes & Endocrine Centre and HealthPlus Diabetes and Endocrinology Center Drive One of the UAE’s Largest Diabetes Awareness Campaigns, Engaging Nearly 4,000 People

18 community, corporate, and government engagements delivered across Abu Dhabi, Al Ain, and Al Dhafra

  • M42’s ICLDEC & HealthPlus Diabetes and Endocrinology Center engaged a record-number of people across Abu Dhabi, Al Ain and Al Dhafra
  • 18 major community, corporate and government activations delivered early detection
  • Free health screenings and expert sessions reached frontline organisations including Mubadala, Aldar, Daman, Modon, HCT, Central Bank of the UAE and Abu Dhabi Police
  • 1,000+ healthcare professionals attended the 3rd Annual Diabetes and Endocrine Conference, strengthening regional clinical expertise
  • 600+ people joined the Diabetes Awareness Run at Zayed Sports Stadium, driving momentum for active living
  • 13 children living with diabetes had wishes granted through Make-A-Wish collaboration

Diabetes Awareness Month took on new meaning across the emirate this year, as nearly 4,000 people engaged with M42’s Imperial College London Diabetes & Endocrine Centre (ICLDEC) and HealthPlus Diabetes & Endocrinology Center through one of the UAE’s most comprehensive, community-driven diabetes initiatives to date.

Across Abu Dhabi, Al Ain, and Al Dhafra, specialist teams from ICLDEC, Moorfields, and HealthPlus Diabetes & Endocrinology Center activated a month-long campaign that brought early detection, specialist education, and meaningful community support directly into workplaces, schools, majlis gatherings, and public spaces. The initiative reached leading corporates such as Mubadala, Aldar, Daman, the Higher Colleges of Technology, Central Bank of the UAE and Abu Dhabi Police.

Through free screenings, expert-led awareness sessions, medical conferences, community events, and family-focused activities, the initiative created impactful moments of engagement, helping individuals understand their risk, supporting people living with diabetes, and empowering families to take control of their health.

The campaign not only raised awareness but also mobilised communities at scale, reinforcing the critical role of prevention, education, and early intervention in reducing the national diabetes burden.

The initiative extended beyond health checks. It sparked conversations, strengthened community bonds, and delivered joy through special activations such as a Make-A-Wish collaborations for paediatric patients, transforming a clinical topic into a movement centered on compassion, prevention, and community wellbeing.

By integrating clinical expertise with community-driven outreach, the programme showcased M42’s commitment to reshaping the future of personalised, proactive, and preventive health across the UAE.

Dr. Mai Ahmed Al Jaber, CEO of Outpatient Care, M42, said: “Diabetes Awareness Month provides an important opportunity for us to engage directly with communities, raise awareness around early detection, and support healthier living. By delivering comprehensive screenings, educational activations, and public events, we are helping individuals better understand their health and empowering families across the emirate to take proactive steps in diabetes prevention and management.” 

Reinforcing their commitment to advancing clinical knowledge, the centres also supported major regional medical events throughout the month. The 3rd Annual Diabetes & Endocrine Conference welcomed more than 1,000 attendees over two days, facilitating scientific exchange and professional learning. ICLDEC physicians chaired and participated in the 7th UAE Obesity Conference, contributing to broader discussions on obesity and metabolic health in the region.

Community engagement remained a central pillar of the month’s initiatives. On 23 November, ICLDEC and HealthPlus Diabetes & Endocrinology Center, in partnership with Abu Dhabi Public Health Center (ADPHC), hosted the Diabetes Awareness Run at Zayed Sports Stadium in Abu Dhabi, attracting more than 600 participants to promote active living and raise awareness of diabetes prevention. Complementing these efforts, Family Fun Days were held in Abu Dhabi and Al Ain for staff and paediatric patients, featuring football, “bike your juice,” canvas painting, face painting, and other interactive activities designed to promote awareness in an engaging, family-friendly environment.

As part of Diabetes Awareness Day on 14 November, the centres partnered with the Make-A-Wish Foundation to grant wishes for 13 pediatric patients living with diabetes. The initiative added a deeply personal dimension to the month’s activities, bringing joy and meaningful support to young patients and their families. 

Dr. Muhaned Attaulah, Senior Director of Clinical Operations, Outpatient Care, M42, said: “Our work throughout Diabetes Awareness Month reflects our broader mission to support individuals and families affected by diabetes. From clinical outreach to community events and collaborations with partners such as Make-A-Wish, every initiative is part of our ongoing commitment to improving lives and reducing the impact of diabetes across the UAE.” 

The collective impact of the month-long campaign positions M42’s ICLDEC and HealthPlus Diabetes & Endocrinology Center as leading drivers of national diabetes awareness, prevention, and long-term health transformation. 

'Make-A-Wish' Celebrates World Diabetes Day by Granting the Wishes of 11 Children at Imperial College London Diabetes & Endocrine Centre and HealthPlus Diabetes and Endocrinology Center

Make-A-Wish Foundation celebrated World Diabetes Day by granting the wishes of 11 children diagnosed with Type 1 diabetes, during a special event held with the generous support of the Abu Dhabi Fund for Development and hosted by both the Imperial College London Diabetes & Endocrine Center and the HealthPlus Diabetes and Endocrinology Center, part of the M42 group.

The event was held at the centre’s premises in the presence of representatives from the Abu Dhabi Fund for Development, Ms. Muna Al Jaber, Board Member of Make-A-Wish Foundation, and Ms. Noha El Shourbagy, Chief Operating Officer of the Foundation, along with a group of physicians, specialists, and the children’s families.

The granted wishes varied between the latest electronic devices, interactive games, and travel experiences, in an atmosphere filled with joy that delighted the children and their families, embodying the Foundation’s mission of spreading hope and bringing smiles to young patients’ faces.

Muna Al Jaber extended her sincere gratitude and appreciation to the Abu Dhabi Fund for Development for its continuous support and noble efforts in enabling the Foundation to grant children’s wishes and bring happiness to their hearts. She emphasized that this support reflects the spirit of giving and social responsibility that characterizes the nation’s institutions and contributes to creating a real and lasting humanitarian impact.

In her remarks on the occasion, Al Jaber expressed the Foundation’s pride in participating in this humanitarian event, saying:

"At Make-A-Wish Foundation, we believe that every child deserves a moment of happiness that lights their path with hope. We are delighted to celebrate World Diabetes Day alongside our partners at the Imperial College London Diabetes and Endocrine Center, the HealthPlus Diabetes and Endocrinology Center, and the Abu Dhabi Fund for Development - united by a noble humanitarian goal to support our young patients and enable them to experience moments filled with joy and positivity.

She added that since its establishment, the Foundation has granted more than 1,600 wishes for children with diabetes from over 80 nationalities around the world, stressing that the Foundation’s humanitarian mission continues, thanks to the tremendous support of partners and sponsors who believe in the value of giving and its positive impact on society.

For his part, H.E. Mohammed Saif Al Suwaidi, Director General of the Abu Dhabi Fund for Development, affirmed that this event aligns with the Fund’s strategic approach to supporting community initiatives. He noted that the Fund’s participation reflects its commitment to strengthening strategic partnerships with various supporting institutions to promote social solidarity and shared responsibility among community members. He added that the Fund places special importance on initiatives related to children’s health, as supporting them is a vital step toward achieving noble humanitarian goals and providing opportunities that offer hope for a brighter future.

Dr. Mai Al Jaber, Chief Executive Officer of Outpatient Clinics at M42—which includes both the Imperial College London Diabetes and Endocrine Centre and the HealthPlus Diabetes and Endocrinology Center—stated:

"At M42, our mission goes beyond providing world-class healthcare; it is about instilling hope and improving quality of life. We are extremely proud of our partnership with Make-A-Wish Foundation and the Abu Dhabi Fund for Development in bringing joy to children living with diabetes. Our physicians witness daily the courage and resilience of these young patients. Seeing their smiles today reminds us that compassion and care lie at the heart of everything we do.

The event concluded with heartfelt moments of pride and gratitude, as Make-A-Wish Foundation reaffirmed its commitment to granting more wishes for children of various backgrounds and nationalities, in alignment with the vision of the UAE’s wise leadership to position the country as a beacon of goodness, humanity, and generosity.

M42’s Imperial College London Diabetes & Endocrine Centre and HealthPlus Diabetes and Endocrinology Center Bring Together 1000+ Experts for Third Annual Diabetes & Endocrine Conference

Abu Dhabi, United Arab Emirates, November 10, 2025: The Imperial College London Diabetes & Endocrine Centre (ICLDEC) and HealthPlus Diabetes & Endocrinology Center, both part of the M42 group, successfully concluded the 3rd Annual Diabetes & Endocrine Conference. The two-day event brought together a diverse spectrum of healthcare professionals – from specialist physicians and clinical researchers to nurses, educators and allied health experts – from across the globe to advance diabetes and endocrine management and patient care through education, collaboration, and innovation, the defining themes of this year’s conference.
Building on the success of the first two editions, this year’s conference convened over 1000 delegates from more than 7 countries, including hospitals, academic institutions, research centres, and industry leaders. Attendees immersed themselves in a dynamic scientific program featuring keynote lectures, interactive case studies, and comprehensive workshops. The conference’s expanded agenda reflected its new, broader scope, incorporating key endocrine topics and underscoring the close interplay between diabetes, hormonal health, and metabolic disorders.
Dr. Mai Ahmed Al Jaber, CEO of Outpatient Care, M42, said: “Our annual conference, held in partnership with the UK’s renowned Imperial College London, has become a vital platform for shaping the future of diabetes and endocrine care. By empowering healthcare professionals with the latest clinical evidence, emerging technologies, and opportunities for meaningful collaboration, we are not only improving patient outcomes but also driving a collective movement towards innovation, education, and long-term impact in diabetes and endocrine management.”

Through a rich, two-day scientific program blending clinical depth with hands-on learning, the 3rd Annual Diabetes & Endocrine Conference delivered an unparalleled platform for advancing clinical expertise. The first day focused on practical diabetes management, featuring sessions on paradigm shifts in Type 2 Diabetes treatment, new approaches to obesity care, and updates on diabetic retinopathy. The day culminated in a lively debate on bariatric surgery and its evolving role in obesity management, alongside parallel workshops that brought real cases from Type 1, Type 2, Pituitary, and Thyroid Clinics to life, allowing delegates to apply insights directly to complex patient scenarios.

The second day expanded into key areas of endocrinology, exploring precision medicine in diabetes, genetics, poly-cystic ovarian syndrome (PCOS) management, and bone health. Sessions also highlighted the growing influence of artificial intelligence, machine learning, and data-driven decision-making in personalising endocrine and metabolic care. The program concluded with discussions on cardiometabolic disease management and innovative therapies addressing dyslipidemia and osteoporosis, reinforcing the conference’s multidisciplinary approach and its newly broadened focus on endocrine health.

Prof. Amir H. Sam, Conference Chair and Head of Imperial College School of Medicine, said: “This conference highlights the power of shared expertise and multidisciplinary collaboration in advancing diabetes and endocrinology. By bringing together leading minds from diverse fields and across the globe, we are transforming cutting-edge research into meaningful clinical impact, and fostering a worldwide community dedicated to improving patient care through innovation and education.”

The spirit of collaboration and continuous learning resonated strongly among attendees, many of whom emphasised the event’s tangible impact on their professional development. One participant, Dr. Mariam Al Hosani, Family Medicine Consultant, commented: “What stood out most was how practical and interactive the sessions were. The case-based workshops and peer-to-peer exchanges brought complex scenarios to life, equipping us with practical tools and strategies we can immediately apply in patient care.”

Another delegate, Richard Flanagai, Nurse Manager, said: “The conference offered an incredible opportunity to connect cutting-edge research with clinical practice. The depth of discussion around emerging therapeutics, AI integration, and real-world data applications provided invaluable insights that will directly inform and strengthen diabetes care.”

The 3rd Annual Diabetes & Endocrine Conference concluded with a renewed sense of purpose and collaboration, uniting the world’s healthcare community in advancing the standards of diabetes and endocrine prevention, management, and patient care. As part of Diabetes Awareness Month, M42 and its network will continue to engage the wider community through a series of public health initiatives, including the Annual Diabetes Walk, scheduled to take place from 6:00am on Sunday, November 23 at Zayed Sports City. Members of the public are encouraged to take part and join healthcare professionals in raising awareness, promoting active living, and supporting the shared goal of reducing the impact of diabetes across the UAE.